The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

Toll-like receptors (TLRs) are vital components of the immune system, acting as sentinels that detect and respond to ...

Patients at Government Wenlock Hospital will now have access to cutting-edge ophthalmology diagnostics with the addition of ...

Equities research analysts at StockNews.com started coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Free Report) in a research note issued to investors on Sunday. The brokerage set a “sell ...

Mytos’ technology will automate the manufacturing of neuronal precursors for Aspen's autologous cell therapy for the brain disorder.

Macular degeneration is a leading cause of vision loss, especially in people over the age of 50. It affects the macula, a ...

Indeed, many myths about cancer are still around and, unfortunately, some people still believe them. Cancer has claimed many ...

Government Wenlock Hospital, is set to elevate its eye care services with the addition of two state-of-the-art ophthalmology ...

The beginning of the new CPD cycle means it is time to prepare a new professional development plan (PDP) and sketch out areas ...

For the past several years, the halls of the Las Vegas Convention Center have been lousy with AR/VR/XR smart glasses. While ...

SolidddVision smartglasses, which correct vision for people living with vision loss due to macular degeneration, will debut at CES.

Phase 1b clinical data underpins sozinibercept’s potential as a novel, first-in-class VEGF-C/D ‘trap’ to improve visual and anatomic outcomes in ...